Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
J Neuroimmunol ; 140(1-2): 194-7, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12864989

RESUMEN

Non-paraneoplastic Lambert-Eaton myasthenic syndrome (LEMS) is an antibody-mediated autoimmune disorder, in which genetically determined interleukin-10 (Il-10) and tumor necrosis factor-alpha (TNF-alpha) could play a role in the susceptibility for the disease. Therefore, we analyzed the production of Il-10 and TNF-alpha after whole-blood stimulation in first-degree family members of patients with LEMS without malignancy, as a measure of innate production in the patients. Thirty-six first-degree family members of 10 patients and 80 healthy controls were studied. Both Il-10 (p=0.037) and TNF-alpha (p=0.0016) production were increased in the family members, but had no relation with the severity of LEMS or HLA-B8DR3 carriership. Our findings suggest that high innate production of Il-10 and TNF-alpha is a susceptibility factor for non-paraneoplastic LEMS.


Asunto(s)
Interleucina-10/biosíntesis , Síndrome Miasténico de Lambert-Eaton/inmunología , Factor de Necrosis Tumoral alfa/biosíntesis , Regulación hacia Arriba/inmunología , Adulto , Susceptibilidad a Enfermedades/inmunología , Femenino , Humanos , Inmunidad Innata/genética , Síndrome Miasténico de Lambert-Eaton/genética , Masculino , Persona de Mediana Edad , Regulación hacia Arriba/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA